Personalized Health Manifesto Endorsers
Read the Manifesto 
| Add your name to the list of endorsers
Following is a list of endorsers of the Personalized Health Manifesto:
| Name |
|
Title |
|
Organization |
|
Comments |
| Amy Speak |
|
Vice President |
|
Porter Novelli |
|
|
| Chris Martin |
|
Doctor |
|
Xenva Ltd |
|
|
| George Bacioiu |
|
Faculty Instructor |
|
University of Windsor |
|
|
| Franck Lescure |
|
Partner |
|
Auriga Partners |
|
|
| Semih Sen |
|
Advisor |
|
Mubadala Healthcare |
|
|
| William A Ghormley |
|
Sr Vice Pres, Bus Dev |
|
Xconomy, Inc |
|
|
| Ashish Soni |
|
|
|
|
|
|
| Scott Morrison |
|
US Life Sciences Leader |
|
Ernst & Young |
|
|
| Vijay Lathi |
|
Managing Director |
|
New Leaf Venture Partners |
|
|
| Neelam Sekhri Feachem |
|
CEO |
|
The Healthcare
Redesign Group Inc. |
|
|
| Ryan Phelan |
|
President & Founder |
|
DNA Direct |
|
|
| Allen Ruszkowski |
|
President & CEO |
|
CVAC Systems, Inc. |
|
The technologies needed currently exist. They need to be implemented. The new health care reform legislation passed this year provides incentives, including grants to employers, starting in 2011, to implement the technologies. Here is a good paper that provides the basis: Preventive Medicine: A Ready Solution for a Health Care System in Crisis Janice L. Clarke Population Health Management, Vol. 13, No. S2: S-3-S-11. |
| Nola Masterson |
|
Managing Director |
|
Science Futures |
|
|
| Francis Russo |
|
Managing Director |
|
Scisive Consulting LP |
|
|
| Rick Mandahl |
|
VP |
|
Uniconnect |
|
|
| Colleen Conklin |
|
CEO |
|
Colleen Conklin
Healthcare Consulting |
|
Integration of healthcare is critical to individuals experiencing mental illness and substance use disorders from those who are experiencing mild distress in their lives to individuals who are not able to function in the community due to the severity of their disability. The history of separation of behavioral health and medical services requires major initiatives in professional and public education; new integrated and collaborative service delivery models; and financing models that supports integrated services rather than is a barrier to these services. I fully support the Manifesto and look forward to helping to facilitate these changes. |
| Raj Gururajan |
|
|
|
|
|
|
| Maria Pop |
|
Outreach and Edu Manager |
|
|
|
|
| Nassir Ghaemi MD |
|
Professor of Psychiatry |
|
Tufts University |
|
|
| Jack Porter |
|
President/CEO |
|
Executive Mindshare |
|
Good job on this David. It was really interesting and clearly the direction of the industry. |
| Esther Dyson |
|
Founder |
|
EDventure Holdings |
|
|
| Charis Eng, MD, PhD |
|
Chair and Director |
|
Genomic Medicine Institute,
Cleveland Clinic |
|
May I add two comments which is alluded to within this but not "called out": 1. Health caregiver time (this is a major issue and a bit of a catch-22. If we succeed, then time is saved but the catch-22 is to begin) 2. When you say tradition, I think it encompasses everything you have said, but also our entire healthcare (and country?s) organisational structure (Micheal Porter would agree with this!). 3. You call for a new specialty of integration but according to what you have written and we agree, integration also includes rigorous evaluation (you call for the study projects but I think saying rigorous, but not painstaking [that delays!], evaluation and integration are part of this new specialty |
| Greg Biggers |
|
Chief Instigator & CEO |
|
http://genomera.com |
|
Integration. Education. ACTION. We will do this. Together. |
| Ellen Wood |
|
|
|
|
|
|
| Garrett Vygantas |
|
EIR |
|
Burrill & Company |
|
|
| Myron Cherry |
|
Attorney |
|
Myron M. Cherry and Associates |
|
|
| Jordan Shlain |
|
MD |
|
Private Medical Services |
|
|
| Kathryn Teng |
|
MD, FACP |
|
Cleveland Clinic |
|
|
| Geoffrey Ginsburg |
|
MD, PhD |
|
Duke University |
|
|
| William Torch |
|
MD, MS |
|
Neuro-Developmental and Neuro-Diagnostic Center
& Washoe Sleep Disorders Center |
|
|
| Emanuel Petricoin |
|
PhD |
|
George Mason University |
|
|
| Keith Grimaldi |
|
Ph.D |
|
Eurogene eTEN |
|
|
| Alice Rathjen |
|
CEO & Founder |
|
DNA Guide |
|
|
| Alexandra Drane |
|
President, Co-Founder |
|
Eliza Corporation |
|
|
| Sarah Stephens Winnay |
|
SVP Market Management |
|
Eliza Corporation |
|
|
| Deepak Chopra |
|
MD |
|
Deepak Chopra LLC |
|
|
| Andrew Hessel |
|
Co-chair, Bioinformatics |
|
Singularity University |
|
|
| George Bacioiu |
|
Faculty Instructor |
|
University of Windsor |
|
Indeed, the future of the humanity's wellbeing is in prevention rather than a blind race for "fixing" when it fails. It is a complete mindset change that will change fundamentally the way we look at the healthcare system. Sooner we find the way to develop a robust prevention system, sooner the systematic problems in our North American healthcare systems will become manageable. Although fundamentally different and apparently requiring different solutions, both, the US healthcare system and its Canadian counterpart can be simultaneously re-invented based on a unique solution: focus on prevention and promoting individual ownership when it comes to it. Waiting to break in order to apply sophisticated solutions to fix it cannot be the solution to the current situation. Great initiative! |
| Stig Albinus |
|
|
|
|
|
|
| Glenn McGee |
|
Editor in Chief |
|
The American Journal of Bioethics |
|
|
| Beth-Ellen Fried, L.Ac., Dipl. Ac., LMT |
|
Fried Acupuncturist, HM |
|
La Paz - Centre for the Art of Medicine |
|
Personalized Healthcare is something the Traditional Chinese medical community has been practicing for thousands of years. Herbal medicine, etc. is dispensed based on each individuals constitution, symptom picture and health goals. When western allopathic medicine learns to integrate it's use and principles fully, taking advantage of both systems, we will have a perfect medicine. |
| |
|
|
|
|
|
|
Expert Panel / Original Endorsers:
The following individuals participated in the development of the Personalized Health Manifesto and have endorsed it:
ADAM GAZZALEY, MD, PhD, neurologist and neuroscientist, University of California at San Francisco
ANTHONY ATALA, MD, board member, Regenerative Medicine Foundation; director, Wake Forest Institute for Regenerative Medicine
ATUL BUTTE, MD, PhD, geneticist and bioinformaticist, Stanford University Medical School
BROOK BYERS, MBA, venture capitalist, Kleiner Perkins Caufield & Byers
CHRIS AUSTIN, MD, neurologist; director, Chemical Genomics Center, National Institutes of Health
DANIEL KRAFT, MD, PhD, oncologist; stem cell researcher, Stanford University Medical School
DAVID AGUS, MD, oncologist, proteomics researcher, entrepreneur, University of Southern California; co-founder, Navigenics
DAVID EWING DUNCAN, journalist and life science policy analyst; director, The Center for Life Science Policy, UC Berkeley
DIETRICH STEPHAN, PhD, geneticist; director, Ignite Institute; co-founder, Navigenics
EDWARD ABRAHAMS, PhD, president, Personalized Medicine Coalition
ERIC SCHADT, PhD, biocomputationist; chief scientific officer, Pacific Biosciences; co-founder, Sage Bionetworks
ERIC TOPOL, MD, cardiologist and translational geneticist; director, Scripps Translational Science Institute
FRANK DOUGLAS, MD, PhD, president and chief executive officer, Austen BioInnovation Institute of Akron, Ohio; founder and first executive director of the MIT Center for Biomedical Innovation, Massachusetts Institute of Technology; former chief scientific officer, Aventis
FRED FRANK, MBA, life sciences investment banker; vice chairman, Peter J. Solomon Company; former vice chairman, Lehman Brothers
GEORGE CHURCH, PhD, molecular biologist, professor of Genetics, and director, Center for Computational Genetics, Harvard Medical School
GEORGE POSTE, PhD, researcher, policy analyst, and former pharmaceutical executive; chief scientist, Complex Adaptive Systems Initiative and professor of Health Innovation, Arizona State University; former president, R&D, of SmithKline Beecham
GREG SIMON, JD, senior vice president for Worldwide Policy, Pfizer; former president, FasterCures; former chief domestic policy advisor to Vice President Al Gore
GREGORY STOCK, PhD, MBA, founding CEO, Signum Biosciences; founding director, Program on Medicine, Technology and Society, University of California at Los Angeles School of Medicine
HANK GREELY, JD, professor of Law, Stanford University; director, Center for Law and the Biosciences
JAMES HEYWOOD, co-founder and chairman, PatientsLikeMe
JAMES THOMSON, VMD, PhD, stem cell scientist; director of Regenerative Biology, The Morgridge Institute for Research, University of Wisconsin School of Medicine and Public Health
JOSHUA ADLER, MD, physician, chief medical officer, University of California at San Francisco Medical Center
LEE HOOD, MD, PhD, molecular biologist and bioinformaticist; founder and director, Institute for Systems Biology
LINDA K. MOLINAR, PhD, entrepreneur, personalized medicine and nanotechnology expert; founding principal, LKM Strategic Consulting
MARGARET ANDERSON, executive director, FasterCures
MARTYN SMITH, PhD, professor of Toxicology, School of Public Health, Division of Environmental Health Sciences, University of California Berkeley
MICHAEL ROIZEN, MD, preventive medicine; director, Wellness Institute, Cleveland Clinic
MISHA ANGRIST, PhD, assistant professor, Duke University Institute for Genome Sciences & Policy
NATHANIEL DAVID, PhD, entrepreneur and venture capitalist; venture partner, Arch Venture Partners
PAUL BILLINGS, MD, PhD, clinical geneticist; director, Genomic Medicine Institute, El Camino Hospital
RAY WOOSLEY, MD, PhD, president and CEO, Critical Path Institute
SAFI BAHCALL, PhD, entrepreneur; CEO, Synta Pharmaceuticals Corp
STEPHEN FRIEND, MD, PhD, president, CEO, co-founder, Sage Bionetworks; former senior vice president and franchise head for Oncology Research, Merck
STEPHEN SPIELBERG, MD, PhD, pediatrician; director, Center for Personalized Medicine and Therapeutic Innovation, Children's Mercy Hospital, Kansas City, Missouri; former dean, Dartmouth Medical School
STEVE WIGGINS, venture capitalist and former health insurance executive; managing director of Essex Woodlands Health Ventures; founder and former CEO, Oxford Health Plans
ZACK LYNCH, executive director, Neurological Industry Organization
